Paul N. Span

Nijmegen, GE, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 156 publications

Survival without treatment of patients with classic and non-classic 21-hydroxylase deficiency.

Survival without treatment of patients with classic and non-classic 21-hydroxylase deficiency.

Journal: The Journal of clinical endocrinology and metabolism
Published: March 26, 2026

Mitochondria-targeted OXPHOS inhibition enhances radiotherapy efficacy by disrupting mitochondrial function.

Mitochondria-targeted OXPHOS inhibition enhances radiotherapy efficacy by disrupting mitochondrial function.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: February 10, 2026

Current insights into monitoring of congenital adrenal hyperplasia.

Current insights into monitoring of congenital adrenal hyperplasia.

Journal: Frontiers in endocrinology
Published: December 23, 2025

Response to Letter to the Editor From Weintrob et al: "Free Cortisol and Free 21-Deoxycortisol in the Clinical Evaluation of Congenital Adrenal Hyperplasia".

Response to Letter to the Editor From Weintrob et al: "Free Cortisol and Free 21-Deoxycortisol in the Clinical Evaluation of Congenital Adrenal Hyperplasia".

Journal: The Journal of clinical endocrinology and metabolism
Published: July 18, 2025

Mitochondria Targeting of Oxidative Phosphorylation Inhibitors to Alleviate Hypoxia and Enhance Anticancer Treatment Efficacy.

Mitochondria Targeting of Oxidative Phosphorylation Inhibitors to Alleviate Hypoxia and Enhance Anticancer Treatment Efficacy.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 04, 2024

Inhibition of OXPHOS induces metabolic rewiring and reduces hypoxia in murine tumor models.

Inhibition of OXPHOS induces metabolic rewiring and reduces hypoxia in murine tumor models.

Journal: Clinical and translational radiation oncology
Published: October 03, 2024

The radiotherapy induced cyclic GMP-AMP-synthase re-localization and immune signature predicts HNSCC treatment efficacy.

The radiotherapy induced cyclic GMP-AMP-synthase re-localization and immune signature predicts HNSCC treatment efficacy.

Journal: Communications medicine
Published: September 16, 2024

Free Cortisol and Free 21-Deoxycortisol in the Clinical Evaluation of Congenital Adrenal Hyperplasia.

Free Cortisol and Free 21-Deoxycortisol in the Clinical Evaluation of Congenital Adrenal Hyperplasia.

Journal: The Journal of clinical endocrinology and metabolism
Published: July 12, 2024

Siglec-7 and Siglec-9 expression in primary triple negative and oestrogen receptor positive breast cancer and in vitro signalling.

Siglec-7 and Siglec-9 expression in primary triple negative and oestrogen receptor positive breast cancer and in vitro signalling.

Journal: Clinical & translational immunology
Published: May 27, 2024

46,XX males with congenital adrenal hyperplasia: a clinical and biochemical description.

46,XX males with congenital adrenal hyperplasia: a clinical and biochemical description.

Journal: Frontiers in endocrinology
Published: March 31, 2024

MitoTam induces ferroptosis and increases radiosensitivity in head and neck cancer cells.

MitoTam induces ferroptosis and increases radiosensitivity in head and neck cancer cells.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: March 11, 2024

Characterizing OXPHOS inhibitor-mediated alleviation of hypoxia using high-throughput live cell-imaging.

Characterizing OXPHOS inhibitor-mediated alleviation of hypoxia using high-throughput live cell-imaging.

Journal: Cancer & metabolism
Published: January 11, 2024
Showing 1-12 of 156

Last Updated: 09/26/2026